Acquisition Announced

J&J acquisition of FireFly Biologics

US$1bn consideration

Announced 2026 (approx.)

Advisers

FireFly Biologics

Target

Financial adviser

J&J

Acquirer

Not disclosed

Target
FireFly Biologics
Acquirer
J&J
Target based in
United States (unverified)
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Oncology

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.